| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0196-9781(98)00057-6 |
| P698 | PubMed publication ID | 9700765 |
| P50 | author | Philip J. Lowry | Q124366298 |
| P2093 | author name string | Woods RJ | |
| Kemp CF | |||
| P2860 | cites work | Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease | Q24303455 |
| Expression cloning of a human corticotropin-releasing-factor receptor | Q24311371 | ||
| Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins | Q24311515 | ||
| A placental clock controlling the length of human pregnancy | Q24313192 | ||
| Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid | Q24313390 | ||
| A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor | Q28242025 | ||
| Isolation of the human plasma corticotrophin-releasing factor-binding protein | Q28253694 | ||
| Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP) | Q28254575 | ||
| Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides | Q28272946 | ||
| Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor | Q28584057 | ||
| Autoproteolysis in hedgehog protein biogenesis | Q28609804 | ||
| Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor | Q29397110 | ||
| Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin | Q29617507 | ||
| Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor | Q33785575 | ||
| Amino acid composition and sequence analysis of sauvagine, a new active peptide from the skin of Phyllomedusa sauvagei | Q34284320 | ||
| A sauvagine/corticotropin-releasing factor receptor expressed in heart and skeletal muscle | Q34311076 | ||
| Adenovirus type 2 endopeptidase: an unusual phosphoprotein enzyme matured by autocatalysis | Q34592470 | ||
| Stimulatory effect of corticotropin-releasing neurohormone on human lymphocyte proliferation and interleukin-2 receptor expression | Q69742012 | ||
| Binding of [125I]corticotropin releasing factor to blood immunocytes and its reduction in Alzheimer's disease | Q69829052 | ||
| Identification of a corticotropin-releasing factor-binding protein in the plasma membrane of AtT-20 mouse pituitary tumor cells and its regulation by dexamethasone | Q70174595 | ||
| Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat | Q70210289 | ||
| Elevated levels of corticotrophin-releasing factor binding protein in the blood of patients suffering from arthritis and septicaemia and the presence of novel ligands in synovial fluid | Q71030924 | ||
| Nature of ligand affinity and dimerization of corticotrophin-releasing factor-binding protein may be detected by circular dichroism | Q71165042 | ||
| Isolation and amino acid sequence of urotensin I, a vasoactive and ACTH-releasing neuropeptide, from the carp (Cyprinus carpio) urophysis | Q71465779 | ||
| Complete amino acid sequence of urotensin I, a hypotensive and corticotropin-releasing neuropeptide from Catostomus | Q72114990 | ||
| Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain. | Q34740438 | ||
| Thyroid function in nephrosis | Q35191855 | ||
| Local secretion of corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis | Q35614089 | ||
| Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary | Q35746693 | ||
| An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene | Q36720562 | ||
| Corticotropin-releasing factor-binding protein ligand inhibitor blunts excessive weight gain in genetically obese Zucker rats and rats during nicotine withdrawal | Q37097648 | ||
| Phosphorylation of insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo: effects on affinity for IGF-I | Q37583391 | ||
| The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF | Q37600348 | ||
| Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. | Q38300073 | ||
| The free hormone hypothesis: a physiologically based mathematical model | Q38688486 | ||
| Plasma protein-mediated transport of steroid and thyroid hormones. A critique | Q39539964 | ||
| Possible placental origin of ACTH in normal human pregnancy | Q39929566 | ||
| Modulatory actions of corticotropin-releasing factor-binding protein | Q40971043 | ||
| Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics | Q41010710 | ||
| Corticotrophin-releasing factor receptors: from molecular biology to drug design | Q41293691 | ||
| Ectodermal patterning in vertebrate embryos | Q41387050 | ||
| The corticotropin releasing hormone gene is expressed in human placenta | Q41431740 | ||
| The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone | Q41480434 | ||
| Identification of a seven transmembrane helix receptor for corticotropin-releasing factor and sauvagine in mammalian brain. | Q41510527 | ||
| Insulin-like growth factors (IGFs) reduce IGF-binding protein-4 (IGFBP-4) concentration and stimulate IGFBP-3 independently of IGF receptors in human fibroblasts and epidermal cells | Q41642226 | ||
| Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. | Q41710815 | ||
| Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts | Q42455102 | ||
| Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex | Q42504479 | ||
| Corticotropin releasing factor binding protein (CRF-BP) is expressed in neuronal and astrocytic cells | Q42514886 | ||
| Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs) -3, -5, and -6 inhibit IGFBP-4 degradation | Q42800345 | ||
| Interferon-beta gene regulation: tandemly repeated sequences of a synthetic 6 bp oligomer function as a virus-inducible enhancer | Q45196821 | ||
| Stimulation of rat B-lymphocyte proliferation by corticotropin-releasing factor | Q46409186 | ||
| Characterization of corticotropin-releasing hormone binding protein in human plasma by chemical cross-linking and its binding during pregnancy | Q46794406 | ||
| The molecular evolution of genes and proteins: a tale of two serines | Q47377727 | ||
| A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity | Q48108608 | ||
| Corticotropin-releasing factor receptors in mouse spleen: identification, autoradiographic localization, and regulation by divalent cations and guanine nucleotides | Q48120891 | ||
| Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat. | Q48365229 | ||
| Corticotropin-releasing factor binding to the anterior pituitary receptor is modulated by divalent cations and guanyl nucleotides | Q48374222 | ||
| Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis | Q48412481 | ||
| Gonadal function and the biological and physicochemical properties of follicle stimulating hormone | Q48656415 | ||
| Appetite-suppressing effects of urocortin, a CRF-related neuropeptide | Q48918115 | ||
| Corticotropin-releasing factor-like activity in human placental extracts | Q48919320 | ||
| Corticotropin-releasing hormone (CRH)-binding protein: reduction in the adrenocorticotropin-releasing activity of placental but not hypothalamic CRH. | Q48961964 | ||
| Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors. | Q52044835 | ||
| Cloning and characterization of human urocortin [published erratum appears in Endocrinoogy 1996 Sep;137(9):3896] | Q55870098 | ||
| Ligand requirements of the human corticotropin-releasing factor-binding protein | Q55969677 | ||
| Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production | Q57174865 | ||
| Plasma measurements of corticotrophin-releasing hormone-binding protein in normal and abnormal human pregnancy | Q57588311 | ||
| Corticotropin releasing hormone-binding protein (CRH-BP): plasma levels decrease during the third trimester of normal human pregnancy | Q57588318 | ||
| Plasma Corticotropin-Releasing Hormone Concentrations During Pregnancy and Parturition* | Q57588345 | ||
| Localization of corticotropin-releasing hormone (CRH) receptor mRNA in adult rat brain by in situ hybridization histochemistry | Q59216305 | ||
| Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women | Q67262346 | ||
| Properties and regulation of high-affinity pituitary receptors for corticotropin-releasing factor | Q67283377 | ||
| Urotensin I and its N-terminal flanking peptide from the flounder, Platichthys flesus | Q68672067 | ||
| Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasma | Q68818357 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 1119-1128 | |
| P577 | publication date | 1998-01-01 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | The corticotrophin-releasing factor-binding protein: an act of several parts | |
| P478 | volume | 19 |
| Q28572089 | A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists |
| Q36821531 | CRF binding protein facilitates the presence of CRF type 2α receptor on the cell surface. |
| Q36021677 | Corticotropin Releasing Factor Binding Protein and CRF2 Receptors in the Ventral Tegmental Area: Modulation of Ethanol Binge Drinking in C57BL/6J Mice |
| Q28568495 | Corticotropin-releasing factor binding protein within the ventral tegmental area is expressed in a subset of dopaminergic neurons |
| Q24313279 | Corticotropin-releasing factor requires CRF binding protein to potentiate NMDA receptors via CRF receptor 2 in dopamine neurons |
| Q48542388 | Corticotropin-releasing hormone (CRH) in the teleost fish Oreochromis mossambicus (tilapia): in vitro release and brain distribution determined by a novel radioimmunoassay |
| Q35119585 | Effects of citalopram on serotonin and CRF systems in the midbrain of primates with differences in stress sensitivity |
| Q34484800 | Genetically engineered mice for studies of stress-related clinical conditions |
| Q48201646 | Localization of corticotropin-releasing factor, urotensin I, and CRF-binding protein gene expression in the brain of the zebrafish, Danio rerio |
| Q34241367 | Mouse models of altered CRH-binding protein expression |
| Q33690311 | Ovarian steroid regulation of the midbrain corticotropin releasing factor and urocortin systems in macaques |
| Q73163719 | Paradoxical activational effects of a corticotropin-releasing factor-binding protein "ligand inhibitor" in rat brain |
| Q73443059 | Pharmacological characterization of recombinant rat corticotropin releasing factor binding protein using different sauvagine analogs |
| Q30487401 | Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs |
| Q34680677 | Reduced mRNA expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer |
| Q24308848 | Residues of corticotropin releasing factor-binding protein (CRF-BP) that selectively abrogate binding to CRF but not to urocortin 1 |
| Q43743002 | Selective stimulatory actions of corticotropin-releasing factor ligands on correlates of energy balance. |
| Q36210642 | Stress and addiction: contribution of the corticotropin releasing factor (CRF) system in neuroplasticity |
| Q34112872 | The CRF peptide family and their receptors: yet more partners discovered |
| Q30473428 | The biology of fear- and anxiety-related behaviors |
| Q52671284 | The corticotropin releasing factor binding protein: A strange case of Dr. Jekyll and Mr. Hyde in the stress system? |
| Q35814456 | The therapeutic potential of CRF1 antagonists for anxiety |
| Q50052128 | Timing of Prenatal Exposure to Trauma and Altered Placental Expressions of HPA-Axis Genes and Genes Driving Neurodevelopment |
| Q78130125 | Urocortin: slower dissociation than corticotropin releasing factor from the CRF binding protein |
Search more.